Solvay Pharma India Ltd. v. PCIT (2018) 169 ITD 13/ 192 TTJ 394 /163 DTR 249 / 62 ITR 643 (Mum) (Trib.)

S. 37(1): Business expenditure -Advertisement , Marketing and business promotion expenses (AMP) by pharmaceutical company for promoting sale and brand was held to be allowable business expenditure. Revision was held to be not valid [ S. 263 ],

Allowing the appeal of the assessee the Tribunal held that , Advertisement , Marketing and business promotion expenses (AMP) by pharmaceutical company for promoting sale and brand , where through conferences and seminars , doctors were updated about latest developments in medical field was held to be allowable business expenditure. Revision was held to be not valid .( AY. 2011-12)